Patients who achieve remission of obesity-related conditions like sleep apnea or fatty liver disease may feel motivated to continue therapy
About this chapter Cite this chapter Abdi, G., Chatterjee, A., Mondol, M.S.A., Akbar, U., Mukherjee, A., Susmitha, T
These drugs have anti-fibrotic characteristics by obstructing transforming growth factor- (TGF-) signaling and diminishing collagen accumulation in models of diabetic nephropathy (Tian et al
A systematic review and meta-analysis of overweight and obese patients showed modest weight loss of 510% led to reduction in LDL-C of 0.20 mmol/dL (8 mg/dL) and triglycerides by 0.13 mmol (12 mg/dL) as well as substantial reduction in blood pressure, fasting plasma glucose, and hemoglobin A1c [26]